Pub. Date : 2015 Sep
PMID : 26122935
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Treatment with Akt1 inhibitor (A-674563), Akt2 inhibitor (CCT128930) and Bcl-xL inhibitor (ABT-263/Navitoclax) significantly decreased the cell survival and vasculogenesis of ECFC co-cultured with or without HPL and implicated activation of the Akt1 pathway as the critical mediator of the HPL effect on ECFC in vitro. | 4-(4-chlorobenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidin-4-amine | AKT serine/threonine kinase 2 | Homo sapiens |